Skip to main content
. 2019 Jun 8;4(4):571–578. doi: 10.1016/j.adro.2019.05.006

Table 2.

Dosimetric parameters of targets and OARs

Variable Value, median (range), %
Breast PTVeval
 V95 98.9 (95.2-99.9)
 V105 7.6 (0-26.1)
Boost PTVeval
 V95 100 (98.6-100)
 V105 3.6 (0-27.3)
Chest wall PTVeval
 V95 97.5 (96.3-98.7)
 V105 8.2 (7.4-8.9)
Heart (all patients)
 V5 2.2 (0-85.6)
 V10 0.2 (0-14.6)
 V20 0 (0-5.2)
 Mean, Gy 1.38 (0.66-5.69)
Heart (Left-sided-only treatments)
 V5 3.4 (0.4-55.9)
 V10 1.1 (0-14.6)
 V20 0.3 (0-5.2)
 Mean, Gy 1.87 (1.21-5.69)
Heart (Right-sided-only treatments)
 V5 0 (0-15.0)
 V10 0 (0-1.3)
 V20 0 (0-0)
 Mean, Gy 1.12 (0.66-1.72)
Heart (Bilateral treatments)
 V5 6.0 (3.1-85.6)
 V10 0.6 (0.1-9.4)
 V20 0.1 (0-1.3)
 Mean, Gy 3.09 (2.96-3.59)
Heart (MV CBCT-only patients)
 V5 2.5 (0-85.6)
 V10 0.1 (0-14.6)
 V20 0 (0-5.2)
 Mean, Gy 1.60 (0.78-5.69)
Heart (kV CBCT-only patients)
 V5 0.4 (0-3.4)
 V10 0 (0-2.0)
 V20 0 (0-1.4)
 Mean, Gy 1.21 (0.66-1.97)
Ipsilateral lung
 V5 32.9 (0-85.0)
 V10 16.9 (0-48.8)
 V20 13.3 (0-35.6)
 Mean, Gy 7.19 (0.75-18.70)

Abbreviations: CBCT = cone beam computed tomography; OAR = organ at risk; PTVeval = planning target volume for evaluation.

Non–6-MV flattening-filter-free O-ring linear accelerator boosts excluded.